Tetrahydroquinoline-based selective estrogen receptor modulators (SERMs)

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 11, 2003, Pages 1907-1910

  Wallace, Owen B ^a   Lauwers, Kenneth S ^a   Jones, Scott A ^a   Dodge, Jeffrey A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ACYLATION; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DEPROTECTION REACTION; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; SUBSTITUTION REACTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0037718356     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00306-8     Document Type: Article

References (18)

1. Selective Estrogen Receptor Modulators. Manni, A., Verderame, M. F., Eds. Humana: Totowa, NJ.
2. Grese T.A., Pennington L.D., Sluka J.P., Adrian M.D., Cole H.W., Fuson T.R., Magee D.E., Phillips D.L., Rowley E.R., Shetler P.K., Short L.L., Venugopalan M., Yang N.N., Sato M., Glasebrook A.L., Bryant H.U. J. Med. Chem. 41:1998;1272.
3. Miller C.P., Collini M.D., Tran B.D., Harris H.A., Kharode Y.P., Marzolf J.T., Moran R.A., Henderson R.A., Bender R.H.W., Unwalla R.J., Greenberger L.M., Yardley J.P., Abou-Gharbia M.A., Lyttle C.R., Komm B.S. J. Med. Chem. 44:2001;1654.
4. Rosati R.L., Jardine P.D., Cameron K.O., Thompson D.D., Ke H.Z., Toler S.M., Brown T.A., Pan L.C., Ebbinghaus C.F., Reinhold A.R., Elliott N.C., Newhouse B.N., Tjoa C.M., Sweetnam P.M., Cole M.J., Arriola M.W., Gauthier J.W., Crawford D.T., Nickerson D.F., Pirie C.M., Qi H., Simmons H.A., Tkalcevic G.T. J. Med. Chem. 41:1998;2928.
5. A structurally distinct series of diphenyl quinolines and isoquinolines has recently been reported: Croisy-Delcey M., Croisy A., Carrez D., Huel C., Chiaroni P., Ducrot P., Bisagni E., Jin L., Leclercq G. Bioorg. Med. Chem. 8:2000;2629.
6. Bell M.R., Zalay A.W., Oesterlin R., Schane P., Potts G.O. J. Med. Chem. 13:1970;664.
7. Fakhfakh M.A., Franck X., Fournet A., Hocquemiller R., Figadere B. Tetrahedron Lett. 42:2001;3847.
8. Gilman H., Gainer G.C. J. Am. Chem. Soc. 69:1947;877.
9. 2 Chem. Pharm. Bull. 36:1988;1529.
10. 2 Chem. Pharm. Bull. 36:1988;1529.
11. 3 deprotection.
12. Schwesinger R., Hasenfratz C., Schlemper H., Walz L., Peters E.M., Peters K., von Schnering H.G. Angew. Chem., Int. Ed. Engl. 32:1993;1361.
13. Hartwig J.F., Kawatsura M., Hauck S.I., Shaughnessy K.H., Alcazar-Roman L.M. J. Org. Chem. 64:1999;5575.
14. Ace K.W., Armitage M.A., Bellingham R.K., Blacker P.D., Ennis D.S., Hussain N., Lathbury D.C., Morgan D.O., O'Connor N., Oakes G.H., Passey S.C., Powling L.C. Org. Proc. Res. Dev. 5:2001;479.
15. The compounds were generally tested in duplicate. The minimum significant ratio (MSR) calculated for the ERα and ERβ binding assays were 2.4 and 2.3, respectively. The MSR for the MCF-7 assay was 2.9.
16. Anstead G.M., Carlson K.E., Katzenellenbogen J.A. Steroids. 62:1997;268.
17. Grese T.A., Adrian M.D., Phillips D.L., Shetler P.K., Short L.L., Glasebrook A.L., Bryant H.U. J. Med. Chem. 44:2001;2857.
18. Shang Y., Brown M. Science. 295:2002;2465.